Atorvastatin attenuates oxidative stress in patients with chronic kidney disease

Med Sci Monit. 2010 Mar;16(3):LE3-3.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Adult
  • Atorvastatin
  • Dinoprost / analogs & derivatives
  • Female
  • Heptanoic Acids / pharmacology*
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Isoprostanes / urine
  • Kidney Failure, Chronic / drug therapy*
  • Kidney Failure, Chronic / urine
  • Male
  • Oxidative Stress / drug effects*
  • Placebos
  • Pyrroles / pharmacology*
  • Pyrroles / therapeutic use*

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Isoprostanes
  • Placebos
  • Pyrroles
  • 8-epi-prostaglandin F2alpha
  • Atorvastatin
  • Dinoprost